论文部分内容阅读
对各种原因的无排卵或排卵功能不全的不孕患者,枸橼酸克罗米芬(CC)是最常用的诱发排卵药。排卵成功率为66～95%,妊娠率仅为52～76%这一差异促使人们探索改善妊娠率的治疗方案。1971年 Murray 及 Osmond-Clarke 提出对 CC 治疗有六种细胞学反应。这一分类不仅增进了我们对用CC 治疗的了解,也丰富了临床医师在治疗排卵障碍的不孕病人作有益的选择。本文修改了 Murray等人描述的反应,根据两个指标:基础体温(BBT)及宫颈粘液(CM)变化,另加三种有各种特点的反应。
Clomiphene citrate (CC) is the most commonly used ovulation induction drug for infertile patients with no or no ovulation for various reasons. The success rate of ovulation 66 ~ 95%, the pregnancy rate was only 52 ~ 76% of the differences prompted people to explore treatment to improve pregnancy rates. In 1971 Murray and Osmond-Clarke proposed six cytological responses to CC treatment. This classification not only enhances our understanding of treatment with CC, but also enriches clinicians’ useful options for treating infertile patients with ovulatory disorders. This article modifies the response described by Murray et al., Based on two indicators: changes in basal body temperature (BBT) and cervical mucus (CM), plus three responses of various traits.